Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02964507
Brief Title: Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer

First Submitted : November 12, 2016
First Submitted that Met QC Criteria : November 12, 2016
First Posted : November 16, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 16, 2021
Last Update Posted : July 22, 2021